Biotricity (BTCY) Competitors $0.28 -0.03 (-10.45%) (As of 01:30 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends BTCY vs. STIM, FEMY, NXGL, NRXS, MDAI, MHUA, IINN, LFWD, NEPH, and PYPDShould you be buying Biotricity stock or one of its competitors? The main competitors of Biotricity include Neuronetics (STIM), Femasys (FEMY), NEXGEL (NXGL), NeurAxis (NRXS), Spectral AI (MDAI), Meihua International Medical Technologies (MHUA), Inspira Technologies Oxy B.H.N. (IINN), ReWalk Robotics (LFWD), Nephros (NEPH), and PolyPid (PYPD). These companies are all part of the "medical equipment" industry. Biotricity vs. Neuronetics Femasys NEXGEL NeurAxis Spectral AI Meihua International Medical Technologies Inspira Technologies Oxy B.H.N. ReWalk Robotics Nephros PolyPid Neuronetics (NASDAQ:STIM) and Biotricity (NASDAQ:BTCY) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk, analyst recommendations and community ranking. Does the MarketBeat Community believe in STIM or BTCY? Neuronetics received 128 more outperform votes than Biotricity when rated by MarketBeat users. Likewise, 68.45% of users gave Neuronetics an outperform vote while only 0.00% of users gave Biotricity an outperform vote. CompanyUnderperformOutperformNeuroneticsOutperform Votes12868.45% Underperform Votes5931.55% BiotricityOutperform VotesNo VotesUnderperform Votes2100.00% Which has better valuation & earnings, STIM or BTCY? Biotricity has lower revenue, but higher earnings than Neuronetics. Neuronetics is trading at a lower price-to-earnings ratio than Biotricity, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeuronetics$71.35M0.35-$30.19M-$1.23-0.67Biotricity$12.06M0.53-$14.09M-$1.37-0.21 Is STIM or BTCY more profitable? Neuronetics has a net margin of -50.09% compared to Biotricity's net margin of -97.05%. Biotricity's return on equity of 0.00% beat Neuronetics' return on equity.Company Net Margins Return on Equity Return on Assets Neuronetics-50.09% -141.24% -32.77% Biotricity -97.05%N/A -221.26% Does the media prefer STIM or BTCY? In the previous week, Biotricity had 3 more articles in the media than Neuronetics. MarketBeat recorded 12 mentions for Biotricity and 9 mentions for Neuronetics. Biotricity's average media sentiment score of 0.23 beat Neuronetics' score of -0.10 indicating that Biotricity is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Neuronetics 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Biotricity 0 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do insiders & institutionals have more ownership in STIM or BTCY? 53.6% of Neuronetics shares are owned by institutional investors. Comparatively, 3.9% of Biotricity shares are owned by institutional investors. 9.8% of Neuronetics shares are owned by company insiders. Comparatively, 10.1% of Biotricity shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has more risk & volatility, STIM or BTCY? Neuronetics has a beta of 2.21, indicating that its share price is 121% more volatile than the S&P 500. Comparatively, Biotricity has a beta of 1.22, indicating that its share price is 22% more volatile than the S&P 500. Do analysts prefer STIM or BTCY? Neuronetics presently has a consensus price target of $4.67, indicating a potential upside of 469.11%. Given Neuronetics' stronger consensus rating and higher possible upside, analysts plainly believe Neuronetics is more favorable than Biotricity.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Neuronetics 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75Biotricity 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryNeuronetics beats Biotricity on 11 of the 18 factors compared between the two stocks. Ad Angel PublishingTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.Click here to get the details. Get Biotricity News Delivered to You Automatically Sign up to receive the latest news and ratings for BTCY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BTCY vs. The Competition Export to ExcelMetricBiotricitySurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.38M$4.48B$5.10B$8.81BDividend YieldN/A36.79%5.04%4.07%P/E Ratio-0.2114.3295.1214.18Price / Sales0.5344.161,217.3088.10Price / CashN/A52.2739.4936.27Price / Book-0.205.786.976.35Net Income-$14.09M$13.76M$118.73M$225.71M7 Day Performance-29.50%-0.47%-1.22%-0.32%1 Month Performance-16.07%1.12%-3.07%1.76%1 Year Performance-69.01%50.87%32.52%27.70% Biotricity Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BTCYBiotricityN/A$0.28-10.4%N/A-66.9%$6.38M$12.06M-0.2140Analyst ForecastAnalyst RevisionNews CoverageSTIMNeuronetics2.3981 of 5 stars$0.82+2.2%$4.67+469.1%-40.6%$24.89M$71.35M0.00180FEMYFemasys2.4841 of 5 stars$1.01+3.4%$10.00+890.1%+2.8%$23.13M$1.07M0.0030Analyst RevisionNXGLNEXGEL1.4395 of 5 stars$3.33+0.9%N/A+84.4%$22.61M$4.09M0.0010NRXSNeurAxisN/A$3.11-2.5%N/A+35.9%$21.71M$2.46M0.0019MDAISpectral AI2.5746 of 5 stars$1.05-0.9%$4.50+328.6%-59.4%$19.52M$18.06M0.0078MHUAMeihua International Medical Technologies0.3433 of 5 stars$0.71+9.8%N/A-66.4%$17.87M$97.10M0.00620Gap UpIINNInspira Technologies Oxy B.H.N.0.3151 of 5 stars$1.33+0.8%N/A+11.3%$16.79MN/A0.0020News CoverageGap UpLFWDReWalk Robotics3.5648 of 5 stars$1.90+2.7%$13.00+584.2%N/A$16.74M$13.85M-0.7460NEPHNephros2.2003 of 5 stars$1.54-3.1%$5.00+224.7%-24.3%$16.23M$14.24M0.0030Gap DownPYPDPolyPid2.877 of 5 stars$3.38-3.2%$12.00+255.0%-14.3%$16.22MN/A0.0080Positive NewsGap Down Related Companies and Tools Related Companies Neuronetics Alternatives Femasys Alternatives NEXGEL Alternatives NeurAxis Alternatives Spectral AI Alternatives Meihua International Medical Technologies Alternatives Inspira Technologies Oxy B.H.N. Alternatives ReWalk Robotics Alternatives Nephros Alternatives PolyPid Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BTCY) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biotricity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biotricity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BTCY Stock Alerts